ArticleNature communications2023

Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice.

Xiaomeng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.